| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/2010 | WO2010083347A2 Peptidomimetic macrocycles |
| 07/22/2010 | WO2010083320A2 Methods and compositions for the inhibition of thrombus formation |
| 07/22/2010 | WO2010083239A2 Therapeutic modulation of vaginal epithelium boundary lubrication |
| 07/22/2010 | WO2010083225A2 Targeted cryptosporidium biocides |
| 07/22/2010 | WO2010083051A2 Cartilage particle tissue mixtures optionally combined with a cancellous construct |
| 07/22/2010 | WO2010083034A1 Methods for increasing adiponectin |
| 07/22/2010 | WO2010082622A1 NOVEL HIGH-FUNCTION ENZYME OBTAINED BY ALTERING SUBSTRATE SPECIFICITY OF HUMAN β-HEXOSAMINIDASE Β |
| 07/22/2010 | WO2010082390A1 Low-concentration nutritional composition |
| 07/22/2010 | WO2010082326A1 Ozone/oxyglutathione ocular perfusion liquid and washing liquid and method of producing the same |
| 07/22/2010 | WO2010082177A2 New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
| 07/22/2010 | WO2010082176A2 Cosmetic composition containing kxk type peptides and uses |
| 07/22/2010 | WO2010082175A2 New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
| 07/22/2010 | WO2010082019A1 Actagardine derivatives, and pharmaceutical use thereof |
| 07/22/2010 | WO2010082018A1 Deoxyactagardine derivatives |
| 07/22/2010 | WO2010081971A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes |
| 07/22/2010 | WO2010081878A1 Mutated antithrombins, a process for preparing the same and their use as drugs |
| 07/22/2010 | WO2010081875A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | WO2010081800A2 New pharmaceutical compositions |
| 07/22/2010 | WO2010081622A2 Food supplement for the treatment of neuropathies |
| 07/22/2010 | WO2010081492A1 Melanocortin analogs with antimicrobial activity |
| 07/22/2010 | WO2010081185A1 Compositions for the treatment of gluten intolerance and uses thereof |
| 07/22/2010 | WO2010062995A3 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| 07/22/2010 | WO2010062394A3 Implantable ocular drug delivery device and methods |
| 07/22/2010 | WO2010059975A3 Method of treatment of atherosclerosis by induction of immunological tolerance to collagen v |
| 07/22/2010 | WO2010037135A3 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| 07/22/2010 | WO2010034015A3 Modulating the alternative complement pathway |
| 07/22/2010 | WO2010032011A3 Anti-fungal therapy |
| 07/22/2010 | WO2010018378A3 Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy |
| 07/22/2010 | WO2010012438A3 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 07/22/2010 | WO2009140659A3 Treating dyspnea associated with acute heart failure with relaxin |
| 07/22/2010 | US20100186102 Methods and compositions for post-transcriptional gene silencing |
| 07/22/2010 | US20100185219 Reinforced biological mesh for surgical reinforcement |
| 07/22/2010 | US20100184951 Truncated BAFF Receptors |
| 07/22/2010 | US20100184845 Myeloid Colony Stimulating Factor and Uses Thereof |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184709 Malt1 specific cleavage in assay and screening method |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184707 Anticonvulsive pharmaceutical compositions |
| 07/22/2010 | US20100184706 Fap-activated chemotherapeutic compounds, and methods of use thereof |
| 07/22/2010 | US20100184705 Therapeutic Peptides and Vaccines |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184703 Use of peptide derivatives for treating pathologies resulting from ischemia |
| 07/22/2010 | US20100184702 Selective High-Affinity Polydentate Ligands and Methods of Making Such |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184700 Preprocalcitonin antigen t epitopes |
| 07/22/2010 | US20100184699 Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184697 Peptide-based stat inhibitor |
| 07/22/2010 | US20100184696 Peptides and Their Use |
| 07/22/2010 | US20100184695 Vascular endothelial cell-binding peptide |
| 07/22/2010 | US20100184694 T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy |
| 07/22/2010 | US20100184693 Methods and systems for generating and evaluating peptides |
| 07/22/2010 | US20100184692 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation |
| 07/22/2010 | US20100184691 Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin |
| 07/22/2010 | US20100184688 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/22/2010 | US20100184687 Purification of Glucagon-Like Peptides |
| 07/22/2010 | US20100184686 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/22/2010 | US20100184685 Systems and methods for treating post- operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein |
| 07/22/2010 | US20100184684 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184683 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184682 Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses |
| 07/22/2010 | US20100184681 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 07/22/2010 | US20100184679 Use of a combination of cart peptides as a therapeutic agent |
| 07/22/2010 | US20100184678 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184676 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184672 Protein c for use in maintaining hemostasis |
| 07/22/2010 | US20100184671 Binding molecules for the treatment of myeloid cell malignancies |
| 07/22/2010 | US20100184670 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
| 07/22/2010 | US20100184669 Compositions and methods for cancer treatment using targeted carbon nanotubes |
| 07/22/2010 | US20100184668 method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 07/22/2010 | US20100184667 Modified plasminogen activator inhibitor type-1 molecule and methods based thereon |
| 07/22/2010 | US20100184666 Novel use of cocoa extract |
| 07/22/2010 | US20100184665 Method for activating receptor by cofactor and method for utilizing ligand activity |
| 07/22/2010 | US20100184664 Ophthalmic compositions useful for improving visual acuity |
| 07/22/2010 | US20100184663 Methods and Compositions Related to Inhibition of Viral Entry |
| 07/22/2010 | US20100184662 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis |
| 07/22/2010 | US20100184661 Conjugate comprising angiostation or its fragment, the method for producing the conjugate and use thereof |
| 07/22/2010 | US20100184660 Single exon genes encoding for novel bio-active peptides |
| 07/22/2010 | US20100184659 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 07/22/2010 | US20100184658 Compositions and methods for diagnosis and treatment of type 1 diabetes |
| 07/22/2010 | US20100184657 Methods of treating epithelial lesions outside the stomach and intestines |
| 07/22/2010 | US20100184656 Pantropic neurotrophic factors |
| 07/22/2010 | US20100184655 Modified erythropoietin |
| 07/22/2010 | US20100184654 Anti-microbial targeting chimeric pharmaceutical |
| 07/22/2010 | US20100184653 Derivates of Polyethylene Glycol Modified Thymosin Alpha 1 |
| 07/22/2010 | US20100184652 Peptide inhibitors of abl kinases |
| 07/22/2010 | US20100184651 Targeted fusion proteins for cancer therapy |
| 07/22/2010 | US20100184650 Treating post-seizure patients |
| 07/22/2010 | US20100184649 Novel antibacterial agents for the treatment of gram positive infections |
| 07/22/2010 | US20100184648 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease |
| 07/22/2010 | US20100184647 Use of Epinecidin-1 Peptides and Anti-lipopolysaccharide Factor Peptides for Treating Microbial Infection |
| 07/22/2010 | US20100184646 Melanocortin receptor ligands modified with hydantoin |
| 07/22/2010 | US20100184645 Stitched polypeptides |